Detalhe da pesquisa
1.
A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses.
Commun Biol
; 5(1): 1066, 2022 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36207580
2.
Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinoma.
Cell Rep Med
; 2(5): 100267, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34095877
3.
Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer.
Sci Rep
; 9(1): 3823, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30846826
4.
BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer.
Oncogene
; 38(28): 5658-5669, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30996246